Undergraduate medical students as future prescribers: Enhancing their participation in adverse drug reaction reporting in India by revising the curriculum [0.03%]
修订印度医学教育课程以增强未来处方医生的药品不良反应报告意识——医学生的作用
Bikash Ranjan Meher,Ajaya Kumar Sahoo,Monalisa Jena
Bikash Ranjan Meher
Anuja Yadav,Vishal Gaurav,Deepika Yadav et al.
Anuja Yadav et al.
Sweet's syndrome is also called as acute febrile neutrophilic dermatosis. Drug-induced Sweet's syndrome was first reported in association with trimethoprim-sulfamethoxazole. It is very rare. To the best of our knowledge, bleomycin-induced S...
Pawan Poddar,Arvinda Podila,Majed Abdul Basit Momin
Pawan Poddar
Ticagrelor is an oral antiplatelet drug. The most common ticagrelor side effects include bleeding, dyspnea, bradycardia and in rare cases, microangiopathic hemolytic anemia. Isolated thrombocytopenia followed by a single-bolus dosage of tic...
A case series of vildagliptin-associated bullous pemphigoid - Rare side effect [0.03%]
维格列汀相关大疱性类天疱疮病例系列分析——罕见的不良反应事件
Mohit Kumar Shahi,J V Ashwin,Astha Singh et al.
Mohit Kumar Shahi et al.
Vildagliptin, among the most commonly used, OHA, belongs to group dipeptidyl peptidase-4 inhibitors for managing type 2 diabetes mellitus, has recently been associated with bullous pemphigoid, characterized by fluid-filled blisters and eros...
Safety assessment of dexmedetomidine: Real-world adverse event analysis from the Food and Drug Administration Adverse Events Reporting System public dashboard [0.03%]
右美托咪定安全性评价：基于美国食品药品监督管理部门不良事件公开报告系统分析
Yi Yin,Jie Jiang,Youpeng Jin
Yi Yin
Dexmedetomidine (DEX), as a widely used medication for sedation, its usage has increased significantly. The concerns about its side effects remain, making a thorough safety evaluation necessary. Data on adverse drug events related to DEX fr...
Dzana Lukac,Tanja Vojinovic,Pinaki Dutta et al.
Dzana Lukac et al.
Background: In this century, antimicrobial resistance (AMR) presents a major public health problem, because it is a leading cause of death worldwide. Antimicrobial resistance is caused by the overprescription of antibioti...
Impact of the timing of antibiotic prophylaxis on the surgical site infections in patients undergoing elective general surgery [0.03%]
择期普通外科手术患者抗生素预防性用药时间对其手术部位感染的影响研究
Aayush Lakkanna,Guguloth Rajender,Yashwant Raj Sakaray et al.
Aayush Lakkanna et al.
Introduction: Surgical site infections are one of the major challenges in surgical practice. The antibiotic prophylaxis, though scientific, still lacks clarity on the timing of the administration of the drugs. ...
Randomized Controlled Trial
Indian journal of pharmacology. 2025 Sep 1;57(5):334-337. DOI:10.4103/ijp.ijp_797_24 2025
Sodium glucose co-transporter 2 inhibitors safety depending on their adverse drug reactions and glucose monitoring parameters in type 2 diabetes mellitus [0.03%]
钠葡萄糖共转运体2抑制剂的安全性取决于其不良反应及血糖监测指标的2型糖尿病患者中的研究
Dhanush Bellapu,Ronald Darwin
Dhanush Bellapu
Introduction: SGLT2 inhibitors have a wide extent of restorative movement and higher chance of hypoglycemia because of their affront autonomous action in treating type 2 diabetes. SGLT2 inhibitors have great security and ...
Synergistic activity of meropenem and sulbactam against carbapenem-resistant Acinetobacter baumannii [0.03%]
美罗培南/舒巴坦联合治疗碳青霉烯类耐药的鲍曼不动杆菌体外试验研究
I Amruthavarshini,Deepashree Rajshekar,Raghavendra Rao et al.
I Amruthavarshini et al.
Objective: The purpose of this study was to determine the in vitro synergistic effect of meropenem and sulbactam drug combinations through checkerboard assay against Carbapenem-resistant Acinetobacter baumannii (CRAB) to ...
In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparedness [0.03%]
针对人副流感病毒融合蛋白和核蛋白的药物再利用的计算机辅助研究：迈向大流行病应对措施的第一步
Harshita Rajput,Gajendra Choudhary,Hadiya Siddiqui et al.
Harshita Rajput et al.
Background: Human metapneumovirus (HMPV) is an emerging respiratory pathogen affecting children, elderly individuals, and immunocompromised patients. Despite its disease burden, no antiviral treatment has been approved to...